Wyoming MPJE (Pharmacy Jurisprudence) Practice Exam 2025 – 400 Free Practice Questions to Pass the Exam

When the FDA grants priority review status to a new drug application, it accelerates the review timeline. This means that the review time for the new drug application is shortened from the standard timeline of 12 months to a quicker timeline of 10 months. Therefore, the correct answer is A: 10, 12.

In the other options:

- Option B (10, 6) is incorrect because priority review does not result in a 6-month review timeline but rather 10 months.

- Option C (12, 6) is incorrect because priority review actually shortens the standard review timeline from 12 months to 10 months.

- Option D (6, 10) is incorrect because the standard review timeline without priority review is usually 12 months, not 6 months.